The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and ...

Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

A new King’s College London study links abdominal fat—not general obesity—to increased psoriasis risk, especially in women, ...

Many Americans unknowingly misidentify various skin conditions, attributing every bump, patch or discoloration to ordinary ...

Some 3.6 million Americans are diagnosed with basal cell carcinoma each year, according to the Skin Cancer Foundation.

The 'normal' mole on mother's arm that turned out to be cancerA top dermatologist has flagged a little-known sign of cancer ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

The new device from Sun Pharma treats the disease in combination with LEVULAN® KERASTICK®, a liquid that contains a substance called aminolevulinic acid and is designed for the treatment of minimally ...

Pronounced “soh-TIK-too,” SOTYKTU is a once-daily pill for adults with moderate to severe plaque psoriasis that works inside ...

Treating psoriasis, a chronic inflammatory skin condition characterized by thick, scaly, red patches that ... resulting in the characteristic plaques that result from the buildup of skin cells.

This common skin condition causes a scaly rash on oily areas of the body ... up to 90% of people with the condition have plaque psoriasis, which causes patches of thick, raised skin, along ...